AZN

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +0.94
Percentage change 1.24	%

Peers: ABBV PFE JNJ MRK NVS BMY GSK SNY LLY AMGN

| Held by: QQQ QQQM PVAL FVD TQQQ DIHP DFIC PPH AVDE QYLD

Index	NDX	P/E	33.95	EPS (ttm)	2.25	Insider Own	0.02%	Shs Outstand	3.10B	Perf Week	-1.24%
Market Cap	237.27B	Forward P/E	15.11	EPS next Y	5.06	Insider Trans	0.00%	Shs Float	3.10B	Perf Month	5.20%
Income	7.04B	PEG	3.06	EPS next Q	1.11	Inst Own	16.79%	Short Float	0.55%	Perf Quarter	11.56%
Sales	54.07B	P/S	4.39	EPS this Y	9.39%	Inst Trans	-0.77%	Short Ratio	3.02	Perf Half Y	-5.73%
Book/sh	13.15	P/B	5.82	EPS next Y	12.78%	ROA	6.86%	Short Interest	16.97M	Perf Year	13.06%
Cash/sh	1.82	P/C	41.97	EPS next 5Y	11.08%	ROE	17.60%	52W Range	62.75 - 87.68	Perf YTD	16.77%
Dividend Est.	1.62 (2.12%)	P/FCF	23.08	EPS past 5Y	34.63%	ROI	10.28%	52W High	-12.73%	Beta	0.48
Dividend TTM	1.55 (2.03%)	Quick Ratio	0.74	Sales past 5Y	17.77%	Gross Margin	72.23%	52W Low	21.93%	ATR (14)	1.29
Dividend Ex-Date	Feb 21, 2025	Current Ratio	0.93	EPS Y/Y TTM	18.11%	Oper. Margin	20.17%	RSI (14)	59.77	Volatility	1.57% 1.38%
Employees	94300	Debt/Eq	0.74	Sales Y/Y TTM	18.03%	Profit Margin	13.01%	Recom	1.39	Target Price	88.47
Option/Short	Yes / Yes	LT Debt/Eq	0.68	EPS Q/Q	56.16%	Payout	66.98%	Rel Volume	1.10	Prev Close	75.57
Sales Surprise	4.67%	EPS Surprise	0.97%	Sales Q/Q	23.84%	Earnings	Feb 06 BMO	Avg Volume	5.62M	Price	76.51
SMA20	1.24%	SMA50	7.11%	SMA200	2.15%	Trades		Volume	6,209,000	Change	1.24%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-13-25	Upgrade	UBS	Neutral → Buy
Feb-12-25	Initiated	Morgan Stanley	Overweight
Nov-20-24	Upgrade	UBS	Sell → Neutral
Nov-06-24	Upgrade	Deutsche Bank	Sell → Hold
Sep-13-24	Downgrade	Deutsche Bank	Hold → Sell
May-30-24	Initiated	Goldman	Buy	$97
Apr-16-24	Upgrade	Deutsche Bank	Sell → Hold
Feb-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jan-23-24	Initiated	Morgan Stanley	Overweight	$85
Jan-16-24	Resumed	UBS	Sell
Jan-03-24	Downgrade	Jefferies	Buy → Hold	$78.50 → $70
Dec-18-23	Initiated	HSBC Securities	Buy	$78
Sep-25-23	Upgrade	Jefferies	Hold → Buy	$66.50 → $80
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-12-23	Upgrade	UBS	Neutral → Buy
Jul-05-23	Downgrade	Deutsche Bank	Buy → Hold
Apr-11-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-05-23	Initiated	BMO Capital Markets	Outperform	$82
Sep-15-22	Downgrade	Credit Suisse	Outperform → Neutral
Sep-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight

Show Previous Ratings

Today 11:55AM	AstraZeneca Stock Nears Buy Point After Long Run In Declining Market (Investor's Business Daily)
Mar-12-25 06:15PM	Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know (Zacks)
04:09PM	Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion (Investor's Business Daily)
Mar-10-25 07:18PM	AstraZeneca and Ionis win EU approval for ATTR polyneuropathy (Pharmaceutical Technology)
06:04AM	AstraZeneca reports positive outcomes from trial of Imfinzi (Clinical Trials Arena)
07:54AM	Loading…
Mar-07-25 07:54AM	AstraZeneca's Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients (Benzinga)
07:00AM	IMFINZI (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers (Business Wire)
Mar-06-25 06:15PM	Astrazeneca (AZN) Stock Moves -0.63%: What You Should Know (Zacks)
Mar-05-25 09:45AM	What Trump's next batch of tariffs could mean for pharma industry (Yahoo Finance Video)
02:04AM	Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com)
Mar-04-25 06:49AM	EU set to approve AstraZenecas Imfinzi-chemo combo for NSCLC (Pharmaceutical Technology)
05:30AM	Daiichi Sankyo and AstraZenecas Enhertu shows OS improvements in Phase III trial (Clinical Trials Arena)
Mar-03-25 07:44AM	Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP (Clinical Trials Arena)
Mar-02-25 11:48AM	Is AstraZeneca PLC (AZN) The Best Immunology Stock To Buy Now? (Insider Monkey)
Mar-01-25 05:30PM	Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps (Business Wire)
02:55PM	Loading…
02:55PM	Is AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts? (Insider Monkey)
Feb-28-25 06:15PM	Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today (Zacks)
07:00AM	Drug Stocks Are the New Safe Bet in a Shaky Market (The Wall Street Journal)
Feb-27-25 05:38AM	AstraZeneca reports positive outcomes from breast cancer combo therapy trial (Clinical Trials Arena)
Feb-26-25 11:05AM	AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds (Insider Monkey)
07:04AM	AstraZeneca breast cancer drug shows positive results, shares up (Investing.com)
07:00AM	Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial (Business Wire)
06:11AM	AstraZenecas next breast cancer drug; Madrigals accelerating MASH launch (BioPharma Dive)
Feb-25-25 02:18PM	Final Trades: Starbucks, Astrazeneca, Western Union and the IYR (CNBC TV)
Feb-24-25 05:27PM	AstraZeneca PLC (AZN): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years (Insider Monkey)
04:00AM	Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing (PR Newswire)
Feb-22-25 11:22PM	AstraZeneca PLC (AZN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts (Insider Monkey)
05:47AM	3 Magnificent Growth Stocks to Buy Right Now (Motley Fool)
Feb-20-25 04:27PM	AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds (Insider Monkey)
04:02PM	FibroGen sells China unit to AstraZeneca for $160m (Pharmaceutical Technology)
07:48AM	Loading…
07:48AM	Heres Why AstraZeneca PLC (AZN) Traded Lower in Q4 (Insider Monkey)
06:40AM	AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal (Reuters)
05:55AM	AstraZeneca deepens China presence with FibroGen deal (BioPharma Dive)
04:16AM	Q4 2024 Ionis Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-17-25 10:15AM	AstraZenecas Imfinzi bladder cancer regimen improves survival in Phase III trial (Clinical Trials Arena)
Feb-15-25 11:15AM	AstraZeneca: IMFINZI improved event-free survival, OS across MIBC (TipRanks)
08:45AM	2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025 (Motley Fool)
Feb-14-25 11:10AM	IMFINZI (durvalumab) perioperative regimen improved event-free survival and overall survival across muscle-invasive bladder cancer patients regardless of complete pathology response status in post-hoc exploratory analysis of NIAGARA Phase III trial (Business Wire)
06:30AM	Is AstraZeneca PLC (AZN) the Best Foreign Dividend Stock to Buy According to Analysts? (Insider Monkey)
05:45AM	Shareholders of AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN (PR Newswire)
Feb-12-25 12:43AM	AstraZeneca PLC (AZN): Among the Best International Dividend Stocks to Buy Now (Insider Monkey)
Feb-11-25 02:36PM	Is AstraZeneca PLC (AZN) the Safest Dividend Stock in the UK? (Insider Monkey)
01:55PM	Final Trades: Trade Desk, Leidos Holdings, Astrazeneca and Devon Energy (CNBC TV)
05:45AM	AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN (PR Newswire)
Feb-10-25 08:17PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
Feb-07-25 02:06AM	AstraZeneca PLC (AZN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges (GuruFocus.com)
Feb-06-25 07:36PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
05:00PM	Why AstraZeneca Topped the Market on Thursday (Motley Fool)
04:15PM	AstraZenecas shares rise as it addresses China investigation (Pharmaceutical Technology)
02:41PM	Pound plunges as Bank of England cuts rates and hints at more to come (The Telegraph)
02:00PM	AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript (Motley Fool)
12:02PM	AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped. (Investor's Business Daily)
11:51AM	AstraZenecas diabetes drug fails to slow Parkinsons progression in UCL trial (Clinical Trials Arena)
09:50AM	Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term (Zacks)
09:46AM	AstraZeneca boss denies falling out with Labour despite scrapping £450m factory (The Telegraph)
09:30AM	Astrazeneca (AZN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:02AM	AstraZeneca Bounds Higher On Fourth-Quarter Beat, Upbeat Guidance (Investor's Business Daily)
08:40AM	AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China (Benzinga)
07:00AM	AstraZenecas Full Year and Q4 2024 results (Business Wire)
06:01AM	AstraZeneca Expects Revenue, Earnings Growth Despite Sales Drop in China (The Wall Street Journal)
05:08AM	Astrazeneca: Q4 Earnings Snapshot (Associated Press Finance)
Feb-05-25 07:00PM	Amazon earnings, FedSpeak, mortgage rates: What to Watch (Yahoo Finance Video)
Feb-04-25 04:15AM	AstraZeneca lung cancer therapy Imfinzi recommended for EU approval (Pharmaceutical Technology)
Feb-03-25 09:16AM	Seeking Clues to Astrazeneca (AZN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
01:00AM	AstraZeneca Stock Rally Will be Tested by Answers on China Probe (Bloomberg)
Jan-31-25 07:01PM	AstraZeneca abandons £450m vaccine factory in blow to Reeves (The Telegraph)
12:11PM	AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government (Associated Press Finance)
Jan-29-25 06:15PM	Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts (Zacks)
11:26AM	FDA expands Enhertu approval to include HER2-ultralow breast cancer patients (Pharmaceutical Technology)
09:40AM	Here's Why Astrazeneca (AZN) is a Strong Value Stock (Zacks)
Jan-28-25 04:52AM	Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer (BioPharma Dive)
04:52AM	Enhertu, with new FDA OK, set to supplant chemo in HER2-low breast cancer (BioPharma Dive)
Jan-27-25 06:00PM	ENHERTU (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies (Business Wire)
Jan-24-25 12:27PM	Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barrons Roundtable (Barrons.com)
09:45AM	Here's Why Astrazeneca (AZN) is a Strong Growth Stock (Zacks)
06:17AM	Mixed results for Keytruda; AbbVie to work with Neomorph (BioPharma Dive)
Jan-23-25 02:31PM	AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery (PR Newswire)
05:00AM	AstraZeneca PLC Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AZN (PR Newswire)
Jan-22-25 03:47PM	Why Is AstraZeneca PLC (AZN) Among the Best Large-Cap Value Stocks to Buy in 2025? (Insider Monkey)
12:48PM	AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi (Pharmaceutical Technology)
Jan-21-25 12:54PM	FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients (Benzinga)
11:57AM	J&Js Lazcluze/Rybrevant combination obtains European approval to treat NSCLC (Pharmaceutical Technology)
07:13AM	AstraZeneca, Daiichis Enhertu successor gets first FDA OK in breast cancer (BioPharma Dive)
Jan-20-25 09:20AM	FDA Approves Two Breakthrough Cancer Treatments for AstraZeneca (GuruFocus.com)
07:54AM	AstraZeneca secures first BTK approval in first-line mantle cell lymphoma (Pharmaceutical Technology)
Jan-18-25 12:31PM	Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year (Yahoo Finance)
08:20AM	Ozempic, Xtandi among next 15 drugs selected for U.S. price talks (TipRanks)
Jan-17-25 05:35PM	DATROWAY (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer (Business Wire)
04:13PM	Medicare to negotiate prices on 15 drugs, including Ozempic (Yahoo Finance Video)
09:46AM	Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations (Yahoo Finance)
08:32AM	AstraZeneca overhauls management of its scandal-hit China division (Financial Times)
07:00AM	Novo shares high-dose Wegovy results; Amgen, AstraZeneca drugs get expanded OKs (BioPharma Dive)
07:00AM	CALQUENCE (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma (Business Wire)
06:42AM	COPD market to expand with AstraZenecas focus on biologics and strong portfolio growth (Pharmaceutical Technology)
05:45AM	AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AZN (PR Newswire)
Jan-15-25 02:57PM	JP Morgan 2025: AstraZeneca promises a catalyst-rich year ahead (Pharmaceutical Technology)
04:58AM	3 High-Yielding Dividend Stocks That Are Trading at Dirt Cheap Prices (Motley Fool)
Jan-14-25 02:14PM	Is AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros Portfolio? (Insider Monkey)
12:53PM	Trade Tracker: Jim Lebenthal buys Astrazeneca (CNBC TV)
05:45AM	AstraZeneca PLC Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN (PR Newswire)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Astrazeneca plc ADR

Upgrade your FINVIZ experience